A clinical trial to study the effect of Qurs Afsanteen in patients with Typhoid Fever

A Single Blind Randomised Controlled Clinical Trial To Evaluate The Safety And Efficacy of Qurs Afsanteen in Humma Miwiyya (Typhoid Fever) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088097

Enrollment

Registered

2025-06-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A010- Typhoid fever

Interventions

Intervention1: QURS AFSANTEEN: 2 capsules-8th hourly 1 capsule is of 1gm each After meals for 14 days Control Intervention1: Cefixime: 200mg twice After meals for 14 days

Eligibility

Inclusion criteria

Inclusion criteria: fever for 3days or more positive Typhi dot test

Exclusion criteria

Exclusion criteria: widal test more than 1:320 pregnant and lactating women other bacterial and viral fever pt.s with intestinal obstruction uncontrolled HTN,DM Renal,cardiac,pulmonary,auto immune diseases

Design outcomes

Primary

Measure	Time frame
To Alleviate the symptoms of Typhoid FeverTimepoint: Once in 2weeks	—

Secondary

Measure	Time frame
To reduce fever, to fight the infection, To prevent complications Timepoint: Once in 2 weeks	—

Countries

India

Contacts

Public ContactDr Faquiha Kareem

Govt.Nizamia Tibbi College

dr.faroqui@gmail.com9849139356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026